Is infection with hypermutable Pseudomonas aeruginosa clinically significant?

Area of Science:

• Microbiology
• Genetics
• Clinical Medicine

Background:

• Hypermutable Pseudomonas aeruginosa (HPA) strains exhibit high mutation rates due to DNA mismatch repair gene defects.
• These isolates are frequently found in cystic fibrosis (CF) patients' sputum and often display multidrug resistance.
• HPA may possess enhanced adaptation to the CF lung environment, but their clinical significance remains unclear.

Purpose of the Study:

• To determine the clinical significance of hypermutable Pseudomonas aeruginosa (HPA) infections in cystic fibrosis (CF) patients.
• To compare clinical outcomes between patients infected with HPA and non-HPA isolates.
• To identify predictors for HPA infection in CF patients.

Main Methods:

• Prospective study of CF patients with Pseudomonas aeruginosa (PA) infection in Jerusalem (2010-2011).
• Mutation frequency of PA isolates determined by rifampicin resistance.
• Analysis included pulmonary function, exacerbations, antibiotic response, and logistic regression for predictors.

Main Results:

• 30% of enrolled CF patients (22/73) were infected with HPA.
• HPA isolates had significantly higher mutation frequencies (2.95×10(-4)) than non-HPA (1×10(-7)).
• No significant differences in pulmonary function, exacerbations, or antibiotic response were observed between HPA and non-HPA groups. Predictors for HPA included multidrug resistance and prior colistin use.

Conclusions:

• Pseudomonas aeruginosa demonstrates significant adaptation to the CF lung environment through hypermutation.
• Infection with hypermutable strains was not associated with poorer clinical outcomes in CF patients.
• Multidrug resistance and inhaled colistin use are associated with HPA infection.